MADRIGAL PHARMACEUTICALS INC

MDGL Shares Dip 1% Amid Volatile Market: What’s Next for Madrigal Pharmaceuticals?

MDGL stock dips 1% amid volatility—find out why Madrigal’s cardiovascular pipeline and upcoming earnings could still spark buying interest.

MADRIGAL PHARMACEUTICALS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

23/10/2026, 15:57

3 minutes to read

MDGL Shares Rise 4.57% as Madrigal Announces Q3 2026 Earnings & Rezdiffra Progress

MDGL shares up 4.57% as Madrigal Pharmaceuticals previews Q3 2026 earnings, highlights Rezdiffra’s EU/US approval and Phase 3 cirrhosis trial progress.

MADRIGAL PHARMACEUTICALS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 22:54

3 minutes to read